Capital Investment Advisors LLC Acquires 596 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Capital Investment Advisors LLC raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 86.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,285 shares of the biotechnology company's stock after buying an additional 596 shares during the period. Capital Investment Advisors LLC's holdings in Axon Enterprise were worth $676,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after buying an additional 275,959 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after acquiring an additional 65,097 shares in the last quarter. Capital World Investors boosted its stake in Axon Enterprise by 86.4% in the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. increased its position in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after acquiring an additional 812,337 shares during the period. Finally, Norges Bank purchased a new stake in Axon Enterprise in the fourth quarter worth about $482,081,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on AXON shares. The Goldman Sachs Group increased their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Northcoast Research cut shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Barclays boosted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, Bank of America lifted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Insider Activity

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction on Monday, May 19th. The stock was sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the transaction, the director now owns 4,829 shares in the company, valued at approximately $3,567,858.36. The trade was a 21.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Brittany Bagley sold 3,400 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total value of $2,380,000.00. Following the transaction, the chief financial officer now owns 131,833 shares in the company, valued at approximately $92,283,100. This trade represents a 2.51% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,969 shares of company stock worth $29,909,594 in the last three months. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Down 0.0%

Axon Enterprise stock traded down $0.15 during midday trading on Thursday, hitting $778.21. The stock had a trading volume of 71,448 shares, compared to its average volume of 720,466. Axon Enterprise, Inc. has a 12 month low of $279.02 and a 12 month high of $806.64. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $60.58 billion, a P/E ratio of 201.09, a P/E/G ratio of 5.17 and a beta of 1.29. The business has a fifty day moving average price of $658.49 and a 200 day moving average price of $619.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 EPS. Research analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.